-
Vaccines, Blood & Biologics
-
Resources for You
-
-
DAPTACEL
Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Tradename: DAPTACEL
Manufacturer: Sanofi Pasteur, Ltd. License #1726
Indications:
- To include a fifth dose booster immunization at 4 to 6 years of age following four previous doses of DAPTACEL.
- Active immunization of infants and toddlers at 2, 4, 6, and 17-20 months of age against diphtheria, tetanus and pertussis.
-
Supporting Documents
- March 12, 2008 Approval Letter - DAPTACEL
To include a fifth dose booster immunization at 4 to 6 years of age following four previous doses of DAPTACEL. - Committee Chair Approval Memo - DAPTACEL
- Clinical Review - DAPTACEL (PDF - 178KB)
- May 14, 2002 Approval Letter - DAPTACEL
Active immunization of infants and toddlers at 2, 4, 6, and 17-20 months of age against diphtheria, tetanus and pertussis. - Clinical Review - DAPTACEL (PDF - 464KB)
-
Contact Us
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-